InMed Pharmaceuticals (INM)

• Market cap: $7.85M
• 1 day: 2.8%
• 5 days: 0%
• 1 month: -11.98%
• 3 months: 111.09%
• 6 months: 57.22%
• Year to date: 31.25%
• 1 year: -34.38%
• 5 years: -99.88%
• 10 years: -99.91%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Employees: 13